Analyst consensus rating
SBC Medical Group Holdings Analyst Rating: Strong Buy
SBC is rated Strong Buy by 4 analysts with a $8.50 target. As of 2026-08-20.
Direct answer
SBC Medical Group Holdings's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.50.
Forecast evidence checked August 20, 2026.
Get free SBC Medical Group Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.68
- Average price target
- $8.50
- High price target
- $10.00
- Low price target
- $7.00
- Low target gap
- +90.2%
- Target upside
- +131%
- High target gap
- +171.7%
- Target range width
- 81.5%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for SBC Medical Group Holdings?
SBC Medical Group Holdings has a verified Strong Buy consensus. The same dataset has an average price target of $8.50.
How far are SBC Medical Group Holdings's low and high targets from the recorded price?
The low target implies +90.2%, while the high target implies +171.7%.
How many analysts are included in SBC Medical Group Holdings's consensus?
The verified consensus includes 4 analysts.
How is SBC Medical Group Holdings's target upside or downside calculated?
The average target of $8.50 is divided by the recorded price of $3.68, then one is subtracted to produce +131%. This does not guarantee a future return.
When was SBC Medical Group Holdings's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.